#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4608	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2850	385.5	0	.	n	.	0	C451T	SNP	451	451	C	1142	1142	T	546	T,C,A	291,210,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	4608	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2850	385.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1875	1875	C	549	C	511	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8392	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4123	484.3	0	.	n	.	0	T695C	SNP	695	695	T	1297	1297	C	577	C,A,T	514,2,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8392	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4123	484.3	0	.	n	.	0	A1638G	SNP	1638	1638	A	2240	2240	G	592	G,A,T	270,288,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8392	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4123	484.3	0	.	n	.	0	T1971C	SNP	1971	1971	T	2573	2573	C	597	C	554	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8392	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4123	484.3	1	SNP	n	A2045G	0	.	.	2045	2045	A	2647	2647	A	584	A,G,C	530,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	8392	23S	2890	2890	99.9	23S.l15.c4.ctg.1	4123	484.3	1	SNP	n	C2597T	0	.	.	2597	2597	C	3199	3199	C	614	C,G	552,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	610	folP	855	855	100.0	folP.l6.c17.ctg.1	2157	67.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1308	1310	AGC	80;81;83	A;G;C,G	72;73;73,1	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1486	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4010	88.8	1	SNP	p	S91F	1	.	.	271	273	TTC	928	930	TTC	116;117;117	T,C;T;C,G,A	100,1;103;105,1,1	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1486	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4010	88.8	1	SNP	p	G95N	0	.	.	283	285	GGC	940	942	GGC	129;132;132	G,T;G,C;C,A	115,1;118,1;113,2	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	1486	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	4010	88.8	1	SNP	p	D95G	1	.	.	283	285	GGC	940	942	GGC	129;132;132	G,T;G,C;C,A	115,1;118,1;113,2	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	27	584	mtrR	633	633	100.0	mtrR.l6.c17.ctg.1	1914	73.0	1	SNP	p	G45D	0	.	.	133	135	GGC	704	706	GGC	152;152;153	G;G;C	137;133;134	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	384	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1477	62.8	0	.	n	.	0	A197.	DEL	197	197	A	783	783	A	143	A	131	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1286	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3563	86.0	1	SNP	p	D86N	0	.	.	256	258	GAC	862	864	GAC	92;93;95	G;A,G;C	73;65,1;69	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1286	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3563	86.0	1	SNP	p	R87I	0	.	.	259	261	CGT	865	867	CGT	93;93;96	C;G,C;T	82;73,1;76	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1286	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3563	86.0	1	SNP	p	R87W	0	.	.	259	261	CGT	865	867	CGT	93;93;96	C;G,C;T	82;73,1;76	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1286	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3563	86.0	1	SNP	p	S87R	1	.	.	259	261	CGT	865	867	CGT	93;93;96	C;G,C;T	82;73,1;76	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1286	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3563	86.0	1	SNP	p	S88P	0	.	.	262	264	TCC	868	870	TCC	97;97;97	T,G,C;C;C	81,1,1;82;83	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1358	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3318	98.6	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1927	1929	GGC	109;110;110	G;G;C	96;96;92	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.002	penA.34.002	1	1	27	1204	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2567	109.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1566	1568	GCC	147;148;148	G;C,G;C	138;138,1;139	penA.34.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1204	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2567	109.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1569	1571	ATG	149;149;147	A;T,G;G,T	139;139,1;137,1	penA.34.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1204	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2567	109.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1581	1583	ACC	151;151;150	A;C;C	139;142;141	penA.34.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1204	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2567	109.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1581	1583	ACC	151;151;150	A;C;C	139;142;141	penA.34.002:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1204	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2567	109.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2082	2084	ACC	140;140;139	A;C,A;C,A	122;125,1;127,1	penA.34.002:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1204	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2567	109.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2136	2138	GCG	129;128;128	G;C;G	111;102;111	penA.34.002:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1204	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2567	109.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2136	2138	GCG	129;128;128	G;C;G	111;102;111	penA.34.002:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1204	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2567	109.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2259	2261	GGT	93;93;93	G;G,T;T,G	85;79,4;83,2	penA.34.002:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1204	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2567	109.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2268	2270	AGC	80;83;84	A,G;G,C;C,G	58,2;65,1;61,1	penA.34.002:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.002	penA.34.002	1	1	27	1204	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2567	109.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2286	2288	CCG	80;80;80	C,G;C,G;G,C	63,3;59,2;66,2	penA.34.002:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1420	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3663	91.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1946	1948	CCG	130;130;130	C,G,A,T;C,G;G,C,T	98,2,1,1;118,1;87,7,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	548	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2427	54.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	848	848	C	46	C	39	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	692	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2164	76.0	0	.	p	.	0	G46D	NONSYN	136	138	GGC	644	646	GAC	104;105;105	G;A,C;C	100;100,1;98	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	692	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2164	76.0	0	.	p	.	0	G140R	NONSYN	418	420	GGA	926	928	AGA	110;110;110	A;G;A	103;102;103	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	692	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2164	76.0	1	SNP	p	G120K	1	.	.	358	360	AAG	866	868	AAG	101;101;101	A,C;A,G;G,A	95,2;96,1;95,2	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	692	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2164	76.0	1	SNP	p	N121D	0	.	.	361	363	AAC	869	871	AAC	101;100;100	A,G;A;C,A	96,1;96;95,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	692	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	2164	76.0	1	SNP	p	A121N	1	.	.	361	363	AAC	869	871	AAC	101;100;100	A,G;A;C,A	96,1;96;95,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2176	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	5353	96.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	290	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1368	52.1	1	SNP	p	V57M	1	.	.	169	171	ATG	767	769	ATG	95;95;97	A;T,A;G	90;93,1;96	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
